(+/-)-BAY K 8644
-
(+/-)-BAY K 8644
structure -
-
CAS No:
71145-03-4
-
Formula:
C16H15F3N2O4
-
Chemical Name:
(+/-)-BAY K 8644
-
Synonyms:
1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-[2'-(TRIFLUOROMETHYL)PHENYL]-3-PYRIDINECARBOXYLIC ACID METHYL ESTER;1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-[2-(TRIFLUOROMETHYL)PHENYL]-3-PYRIDINECARBOXYLIC ACID, METHYL ESTER;1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-[TRIFLUOROMETHYL]PHENYL)PYRIDINE-3-CARBOXYLIC ACID METHYL ESTER;(+/-)-BAY K 8644;BAY K-8644 (+/-);3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-diMethyl-5-nitro-4-[2-(trifluoroMethyl)phenyl]-, Methyl ester;methyl 2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate;(+/-)-BAY K8644 CALCIUM SLOW CHANNEL
-
CAS No:
Description
yellow powder
Methyl 2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate is a pentasubstituted dihydropyridine carrying methoxycarbonyl, 2-(trifluoromethyl)phenyl and nitro substituents at positions 3, 4 and 5 respectively as well as two methyl substituents at positions 2 and 6. It is a dihydropyridine, a methyl ester, a C-nitro compound and a member of (trifluoromethyl)benzenes.|A dihydropyridine derivative, which, in contrast to NIFEDIPINE, functions as a calcium channel agonist. The compound facilitates Ca2+ influx through partially activated voltage-dependent Ca2+ channels, thereby causing vasoconstrictor and positive inotropic effects. It is used primarily as a research tool.
BAY K8644 (71145-03-4) is an L-type Ca2+-channel activator with positive inotropic and vasoconstrictive effects.
Characteristics
84.2
4.19940
yellow powder
1.3548 (estimate)
166 °C
429.2±45.0 °C(Predicted)
198.3ºC
1.545
Soluble in DMSO at 20mg/ml. Also soluble in methanol or ethanol at 60mg/ml. Insoluble in water
2-8°C
-3.43±0.70(Predicted)
2-8°C
Safety Information
NONH for all modes of transport
3
Xi
26-36
US5655000
Xi
+4°C
Stable. Incompatible with strong oxidizing agents.
P305 + P351 + P338
36/38
|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, and P362|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Agents that increase calcium influx into calcium channels of excitable tissues. This causes vasoconstriction in VASCULAR SMOOTH MUSCLE and/or CARDIAC MUSCLE cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. They have been used primarily in experimental studies in cell and tissue culture. (See all compounds classified as Calcium Channel Agonists.)
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
Computed Properties
Molecular Weight:356.30
XLogP3:3.4
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:8
Rotatable Bond Count:3
Exact Mass:356.09839145
Monoisotopic Mass:356.09839145
Topological Polar Surface Area:84.2
Heavy Atom Count:25
Complexity:634
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
Antibiotic K 41, 6,15-didemethoxy-27-de((tetrahydro-5-methoxy-6-methyl-2H-pyran-2-yl)oxy)-18-((tetrahydro-5-methoxy-6-methyl-2H-pyran-2-yl)oxy)-
69421-39-2
-
K 02288
1431985-92-0
-
Ganoderic acid K
104700-95-0
-
Dehydromonacolin K Formula
109273-98-5
-
(-)-(S)-Bay K 8644 Formula
98625-26-4
-
Woodward's Reagent K Formula
4156-16-5
-
Vitamin K epoxide Structure
25486-55-9
-
Ginsenoside K Structure
39262-14-1
-
What is Proteinase K
39450-01-6
-
What is Antibiotic K 41, monosodium salt
69307-91-1